Investor Relations
Corporate Profile
Arcutis Biotherapeutics (NASDAQ: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.
The company’s strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders.
Latest Quarterly Earnings
News
Apr 12, 2021
Mar 26, 2021
Mar 18, 2021
Events
Mar 1, 2021 at 3:20 PM EST
Feb 1, 2021 at 8:30 AM EST
Dec 9, 2020 at 11:00 AM EST